RRM2 and glioblastoma: Among the top 50 of DEGs, RRM2 was closely correlated with DNA replication, cell cycle, lysosomal and proteasome pathways, so we hypothesized that RRM2 may be a key target gene for the anti-tumor effect of PECT on GBM.